Cynapsedx
WebCynapseDx Company Name CynapseDx Main Industry Business Services, Research & Development Website www.cynapsedx.com Contact Information Headquarters 131 Mount Pleasant, Liverpool, England, L3 5TF, United Kingdom … WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is an antibody coated large ultra-dense …
Cynapsedx
Did you know?
Webcynapsedx.com Claim your profile to get in front of buyers, investors, and analysts. Submit Your Analyst Briefing Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more. Overview & Products Financials People Alternatives & Competitors Customers CynapseDx has not claimed their Profile. WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is an antibody coated large ultra-dense …
WebCynapseDx is currently conducting a trial to demonstrate that our assays can save money and resources for any health service by cost effectively identifying patients mis-diagnosed with Parkinson’s disease. This will secure the funding to complete the development of all 3 assays for ß-amyloid, α-synuclein and phospho-tau. ... WebSummary Overview Number of Founded Organizations 1 CB Rank (Person) 672,540 Gender Male Christopher Stanley is the co-founder of CynapseDx. Jobs Number of Current Jobs 1 Christopher Stanley is the Co-Founder & CTO at CynapseDx. CynapseDx Co-Founder & CTO Recent News and Activity There is no recent news or activity for this profile.
http://email.cynapsedx.com/partnering http://cynapsedx.com/technology/
Webwww.cynapsedx.com/about-us Formerly Known As Cell Cap Technologies Ownership Status Acquired/Merged (Operating Subsidiary) Financing Status Formerly VC-backed …
WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is a concentration step, which enriches the … how many petals are on a flowerWebCynapseDx is the new name for CellCap Technologies. The new name better reflects our focus on development of blood tests for Parkinson's and Alzheimer's diseases. It builds on the… Chief... how change alpabet to greek on microsofthttp://mta.cynapsedx.com/partnering how change alarm sound iphonehttp://forum.cynapsedx.com/ how change alarm volume iphoneWebCynapseDx Connect to CRM Summary Financials People Technology Signals & News Similar Companies Highlights Employee Profiles 2 About CynapseDx has 2 current employee profiles, including Co-Founder & CTO Christopher Stanley. Contacts We're working on getting contact data for CynapseDx Find more contact data in Search! Get … how change amazon languageWebCynapseDx develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from a neurodegenerative disease, such as Alzheimer's or Parkinson's Diseases. how change airtag batteryWebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from neurodegenerative diseases. View company Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via … how many petals does a flower have